人工心臓市場：製品、材料、用途、エンドユーザー別-2025-2030年の世界予測

人工心臓市場の2023年の市場規模は25億4,000万米ドルで、2024年には28億2,000万米ドルに達すると予測され、CAGR 11.27％で成長し、2030年には53億7,000万米ドルに達すると予測されています。

人工心臓市場は、機能不全に陥った人間の心臓の機能を代替する機械装置と定義され、心血管系疾患の増加、医療技術の進歩、心不全の効果的な解決策を求める高齢化人口の増加が市場を牽引しています。心臓移植が不可能な場合に不可欠な人工心臓は、移植への橋渡しや恒久的な解決策の役割を果たします。主な用途には、慢性心疾患患者への使用、死亡率の低下、患者の生活の質の向上などがあります。市場のエンドユーザーは、病院、心臓専門医療センター、外来手術センターなど多岐にわたる。

ヘルスケア投資の急増と有利な政府政策が影響力のある成長要因です。さらに、生体材料やエレクトロニクスの技術進歩、ヘルスケアインフラの強化、心臓関連の合併症に対する意識の高まりが市場成長を後押ししています。新たなビジネスチャンスは、人工知能の統合、デバイスモニタリングにおけるIoTの活用、患者固有の治療計画を強化する個別化医療にあります。しかし、デバイスの高コスト、規制上のハードル、熟練した専門家の不足といった課題が市場の拡大を抑制しています。さらに、デバイスの誤動作リスクや発展途上地域での限られた利用可能性といった問題は、潜在的な制約を浮き彫りにしています。

事業成長のためには、生体適合性を高め免疫拒絶反応を低減するための生分解性材料の革新、小型化技術、体内デバイス用ワイヤレス充電技術の開発が主要研究分野です。最先端の研究開発のためのバイオテクノロジー企業と大学とのコラボレーションや、戦略的なM&Aは、競合のポジショニングを強化する可能性があります。市場の進化を考えると、コストのばらつきに対処し、人工心臓の利点に関する患者教育を改善する一方で、新興国での市場浸透戦略にも重点を置く必要があります。このような分野への洞察に満ちた投資は、人工心臓業界における受容の拡大と技術的進歩を活用し、大きなリターンをもたらす可能性が高いです。

市場力学：急速に進化する人工心臓市場の主要市場インサイトを公開

人工心臓市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人工心臓ソリューションの需要増加につながる、世界の心血管疾患の有病率の増加
  • 人工心臓技術の絶え間ない進歩と臨床結果の向上が市場成長を促進
  • 人工心臓の開発と採用を促進するヘルスケア支出の増加と政府の支援政策
  • 人工心臓市場の拡大を後押しする、心臓疾患に罹患しやすい高齢者人口の増加
• 市場抑制要因
  • 適切なドナー臓器が限られていることが人工心臓デバイスの市場成長に大きく影響
  • 人工心臓開拓における技術的・工学的課題が信頼性と市場満足度に影響
• 市場機会
  • 3Dプリンティングとカスタマイズによる個別化人工心臓ソリューションの拡大
  • ヘルスケアプロバイダーとの連携による、データ主導型の術後ケアプログラムの確立
  • AI・機械学習による人工心臓機能の予知保全と最適化
• 市場課題
  • 包括的なウェブクロールによる市場課題の情報収集
  • 包括的なウェブクロールによる業界固有の市場課題に関する情報収集

ポーターの5つの力：人工心臓市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、人工心臓市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：人工心臓市場における外部からの影響の把握

外部マクロ環境要因は、人工心臓市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析人工心臓市場における競合情勢の把握

人工心臓市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス人工心臓市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、人工心臓市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨人工心臓市場における成功への道筋を描く

人工心臓市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で心血管疾患の罹患率が上昇し、人工心臓ソリューションの需要が高まっています。
    • 人工心臓技術の継続的な進歩と臨床結果の改善が市場の成長を牽引
    • ヘルスケア費の増加と人工心臓の開発と導入を促進する政府の支援政策
    • 心臓病にかかりやすい高齢者人口の増加が人工心臓市場の拡大を促進
  • 抑制要因
    • 適切なドナー臓器の入手が限られているため、人工心臓デバイスの市場成長に大きく影響しています。
    • 人工心臓開発における技術的およびエンジニアリング的課題は信頼性と市場満足度に影響を与える
  • 機会
    • 3Dプリントとカスタマイズによるパーソナライズされた人工心臓ソリューションの拡大
    • ヘルスケア提供者との連携によるデータ駆動型術後ケアプログラムの構築
    • 人工心臓機能の予知保全と最適化のためのAIと機械学習の実装
  • 課題
    • 市場の課題に関する情報を収集するための包括的なウェブクロール
    • 業界特有の市場課題に関する情報を収集するための包括的なウェブクロール
• 市場セグメンテーション分析
  • 製品：両心室性心不全患者に対するトータル人工心臓デバイスの活用
  • エンドユーザー：個別化された集中的な患者ケアのための専門心臓センターにおける人工心臓の需要が高まっています
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 人工心臓市場：製品別

• 合計人工心臓
• 補助人工心臓

第7章 人工心臓市場：素材別

• 生物材料
  • 生体模倣材料
  • 組織工学材料
• 合成素材
  • セラミックス
  • 金属
  • ポリマー

第8章 人工心臓市場：用途別

• 回復への架け橋
• 移植への架け橋
• デスティネーションセラピー

第9章 人工心臓市場：エンドユーザー別

• 病院
• 専門心臓センター

第10章 南北アメリカの人工心臓市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の人工心臓市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの人工心臓市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • エバーストーン・キャピタル、トランスルミナ・セラピューティクスとエバーライフ・ホールディングスを合併、IPOに先立ち10億米ドル規模のヘルスケア大手を誕生
  • BiVACORは、急成長する866億米ドルの心臓血管市場をターゲットに、2024年にワイヤレス駆動の総合人工心臓試験を推進するために1,300万米ドルのMRFF助成金を獲得しました。
  • Carmatは、リアルタイム安全ソフトウェアでaeson人工心臓を強化し、患者の安全性の向上と世界市場の拡大を目指します。
• 戦略分析と提言

企業一覧

• ALung Technologies
• Asahi Kasei Corporation
• Baxter International Inc.
• Boston Scientific Corporation
• CytoSorbents Corporation
• Getinge AB
• Henry Schein, Inc.
• LivaNova PLC
• Merit Medical Systems
• MicroPort Scientific Corporation
• Nipro Corporation
• NuPulseCV
• Pfizer Inc.
• Procyrion Inc.
• Spectranetics
• TandemLife
• Terumo Corporation
• Transonic Systems Inc
• Zimmer Biomet Holdings
• Zoll Medical Corporation

LIST OF FIGURES

• FIGURE 1. ARTIFICIAL HEART MARKET RESEARCH PROCESS
• FIGURE 2. ARTIFICIAL HEART MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ARTIFICIAL HEART MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ARTIFICIAL HEART MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ARTIFICIAL HEART MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ARTIFICIAL HEART MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ARTIFICIAL HEART MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ARTIFICIAL HEART MARKET DYNAMICS
• TABLE 7. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIOMIMETIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TISSUE-ENGINEERED MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY CERAMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY METALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CANADA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 48. CANADA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 49. CANADA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 50. CANADA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. CHINA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. CHINA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 80. CHINA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 81. CHINA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 82. CHINA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. CHINA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDIA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. INDIA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 86. INDIA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 87. INDIA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 88. INDIA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. INDIA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. SINGAPORE ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. SINGAPORE ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SOUTH KOREA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH KOREA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. TAIWAN ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. TAIWAN ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. THAILAND ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. THAILAND ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. VIETNAM ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. VIETNAM ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 151. DENMARK ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. DENMARK ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. EGYPT ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. EGYPT ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. FINLAND ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. FINLAND ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. FRANCE ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. FRANCE ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. GERMANY ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. GERMANY ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. ISRAEL ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. ISRAEL ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. ITALY ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. ITALY ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 189. ITALY ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 190. ITALY ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 191. ITALY ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. ITALY ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. NETHERLANDS ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. NETHERLANDS ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. NIGERIA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. NIGERIA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. NORWAY ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. NORWAY ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. POLAND ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. POLAND ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 213. POLAND ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 214. POLAND ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 215. POLAND ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. POLAND ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. QATAR ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. QATAR ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 219. QATAR ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 220. QATAR ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 221. QATAR ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. QATAR ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. RUSSIA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. RUSSIA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. SAUDI ARABIA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. SAUDI ARABIA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. SOUTH AFRICA ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH AFRICA ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. SPAIN ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 242. SPAIN ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 247. SWEDEN ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 248. SWEDEN ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. SWITZERLAND ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 254. SWITZERLAND ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 259. TURKEY ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 260. TURKEY ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 265. UNITED ARAB EMIRATES ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 266. UNITED ARAB EMIRATES ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 271. UNITED KINGDOM ARTIFICIAL HEART MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 272. UNITED KINGDOM ARTIFICIAL HEART MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM ARTIFICIAL HEART MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM ARTIFICIAL HEART MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM ARTIFICIAL HEART MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 277. ARTIFICIAL HEART MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 278. ARTIFICIAL HEART MARKET, FPNV POSITIONING MATRIX, 2023

The Artificial Heart Market was valued at USD 2.54 billion in 2023, expected to reach USD 2.82 billion in 2024, and is projected to grow at a CAGR of 11.27%, to USD 5.37 billion by 2030.

The market for artificial hearts, defined as mechanical devices that replace the function of a failing human heart, is driven by increasing incidences of cardiovascular diseases, advancements in medical technology, and a growing aging population demanding effective solutions for heart failure. Essential in cases where heart transplants are not viable, artificial hearts serve as a bridge-to-transplant or permanent solution. Key applications include use in patients with chronic heart diseases, reducing the mortality rate and improving patient life quality. The market end-users span hospitals, specialty cardiac care centers, and ambulatory surgical centers.

A surge in healthcare investment and favorable government policies are influential growth factors. Additionally, technological advancements in biomaterials and electronics, enhanced healthcare infrastructure, and a rising awareness regarding heart-related complications propel market growth. Emerging opportunities lie in the integration of artificial intelligence, harnessing IoT in device monitoring, and personalized medicine to enhance patient-specific treatment plans. However, challenges such as high costs of devices, regulatory hurdles, and lack of skilled professionals restrain market expansion. Moreover, issues like device malfunction risks and limited availability in developing regions highlight potential constraints.

For business growth, innovation in biodegradable materials to increase biocompatibility and reduce immune rejection, miniaturization techniques, and development of wireless charging technology for internal devices are key areas of research. Collaborations between biotech firms and universities for cutting-edge R&D, along with strategic mergers and acquisitions, can enhance competitive positioning. Given the market's evolving nature, emphasis should also be placed on market penetration strategies in emerging economies while addressing cost variability and improving patient education on the benefits of artificial hearts. Insightful investments in these areas will likely yield significant returns, capitalizing on the widening acceptance and technological advancements within the artificial heart industry.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Heart Market

The Artificial Heart Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of cardiovascular diseases worldwide leading to increased demand for artificial heart solutions
  • Continuous advancements in artificial heart technology and improved clinical outcomes driving market growth
  • Increased healthcare spending and supportive government policies promoting development and adoption of artificial hearts
  • Rising geriatric population with higher susceptibility to heart diseases boosting artificial heart market expansion
• Market Restraints
  • Limited availability of suitable donor organs significantly affects market growth for artificial heart devices
  • Technical and engineering challenges in artificial heart development impact reliability and market satisfaction
• Market Opportunities
  • Expansion of personalized artificial heart solutions through 3D printing and customization
  • Collaboration with healthcare providers to establish data-driven postoperative artificial heart care programs
  • Implementation of AI and machine learning for predictive maintenance and optimization of artificial heart functions
• Market Challenges
  • Comprehensive web crawl to gather information on market challenges
  • Comprehensive web crawl to gather information on industry-specific market challenges

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Heart Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Heart Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Heart Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Heart Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Heart Market

A detailed market share analysis in the Artificial Heart Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Heart Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Heart Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Heart Market

A strategic analysis of the Artificial Heart Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Heart Market, highlighting leading vendors and their innovative profiles. These include ALung Technologies, Asahi Kasei Corporation, Baxter International Inc., Boston Scientific Corporation, CytoSorbents Corporation, Getinge AB, Henry Schein, Inc., LivaNova PLC, Merit Medical Systems, MicroPort Scientific Corporation, Nipro Corporation, NuPulseCV, Pfizer Inc., Procyrion Inc., Spectranetics, TandemLife, Terumo Corporation, Transonic Systems Inc, Zimmer Biomet Holdings, and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Artificial Heart Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Total Artificial Heart and Ventricular Assist Devices.
• Based on Material, market is studied across Biological Materials and Synthetic Materials. The Biological Materials is further studied across Biomimetic materials and Tissue-engineered materials. The Synthetic Materials is further studied across Ceramics, Metals, and Polymers.
• Based on Application, market is studied across Bridge to Recovery, Bridge to Transplantation, and Destination Therapy.
• Based on End-User, market is studied across Hospitals and Specialized Cardiac Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of cardiovascular diseases worldwide leading to increased demand for artificial heart solutions
    • 5.1.1.2. Continuous advancements in artificial heart technology and improved clinical outcomes driving market growth
    • 5.1.1.3. Increased healthcare spending and supportive government policies promoting development and adoption of artificial hearts
    • 5.1.1.4. Rising geriatric population with higher susceptibility to heart diseases boosting artificial heart market expansion
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of suitable donor organs significantly affects market growth for artificial heart devices
    • 5.1.2.2. Technical and engineering challenges in artificial heart development impact reliability and market satisfaction
  • 5.1.3. Opportunities
    • 5.1.3.1. Expansion of personalized artificial heart solutions through 3D printing and customization
    • 5.1.3.2. Collaboration with healthcare providers to establish data-driven postoperative artificial heart care programs
    • 5.1.3.3. Implementation of AI and machine learning for predictive maintenance and optimization of artificial heart functions
  • 5.1.4. Challenges
    • 5.1.4.1. Comprehensive web crawl to gather information on market challenges
    • 5.1.4.2. Comprehensive web crawl to gather information on industry-specific market challenges
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Utilization of total artificial heart device for biventricular heart failure patients
  • 5.2.2. End-Users: Growing demand of artificial heart in specialized cardiac center for personalized and intensive patient care
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Heart Market, by Product

• 6.1. Introduction
• 6.2. Total Artificial Heart
• 6.3. Ventricular Assist Devices

7. Artificial Heart Market, by Material

• 7.1. Introduction
• 7.2. Biological Materials
  • 7.2.1. Biomimetic materials
  • 7.2.2. Tissue-engineered materials
• 7.3. Synthetic Materials
  • 7.3.1. Ceramics
  • 7.3.2. Metals
  • 7.3.3. Polymers

8. Artificial Heart Market, by Application

• 8.1. Introduction
• 8.2. Bridge to Recovery
• 8.3. Bridge to Transplantation
• 8.4. Destination Therapy

9. Artificial Heart Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Specialized Cardiac Centers

10. Americas Artificial Heart Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Artificial Heart Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Heart Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Everstone capital to merge translumina therapeutics and everlife holdings, creating a USD 1 Billion healthcare giant ahead of IPO
  • 13.3.2. BiVACOR secures USD 13M MRFF grant to propel wireless-powered total artificial heart trials in 2024, targeting booming USD 86.6B cardiovascular market
  • 13.3.3. Carmat enhances aeson artificial heart with real-time safety software, targets improved patient safety and global market expansion
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ALung Technologies
• 2. Asahi Kasei Corporation
• 3. Baxter International Inc.
• 4. Boston Scientific Corporation
• 5. CytoSorbents Corporation
• 6. Getinge AB
• 7. Henry Schein, Inc.
• 8. LivaNova PLC
• 9. Merit Medical Systems
• 10. MicroPort Scientific Corporation
• 11. Nipro Corporation
• 12. NuPulseCV
• 13. Pfizer Inc.
• 14. Procyrion Inc.
• 15. Spectranetics
• 16. TandemLife
• 17. Terumo Corporation
• 18. Transonic Systems Inc
• 19. Zimmer Biomet Holdings
• 20. Zoll Medical Corporation